GoingToMeet

SMi is proud to present the 7th annual conference in its series on imaging for the purposes of developing novel cancer therapies.  Imaging in Cancer Drug Development will build on the success of the previous 6 years to bring your knowledge in this field in line with the latest developments.

Taking place in central London, UK, you will hear presentations from the key players in the cancer and imaging arena.  The conference will focus on a wide range of imaging techniques in a wide range of settings - from the preclinical, to the clinical, to the future of oncological imaging.  You will hear presentations from the leading experts in their fields on the latest developments in MRI, PET, SPECT, IR and more.

Attend this event and learn how best to use imaging techniques to expedite your oncology drug development process.

Key topics covered by the conference include:

• New techniques: the latest in new techniques and procedures for MRI, PET, SPECT and Mass Spectrometry
• Clinical imaging with a focus on breast cancer
• Preclinical imaging with a view to developing personalised cancer therapies
• Future developments and improving the safety of imaging technologies

Hear from our excellent speaker line-up, Including:

• Helen Young, Imaging Specialist, AstraZeneca
• Jan Passchier, Director, PET and Radiochemistry, GlaxoSmithKline
• Werner Scheuer, Group Leader, Preclinical Optical Imaging, Pharmacology TR-PD, Pharmaceutical Research, Roche
• Rainer Kneuer, Investigator III, Novartis Institutes for Biomedical Research

PLUSE AN INTERACTIVE PRE-CONFERENCE WORKSHOP ON
Challenges of Using Imaging in Oncology Clinical Trials
9th March 2011, Copthorne Tara Hotel, London
In association with Nexus Oncology